Ameloblastic fibroma and related lesions: current pathologic concept

Area of Science:

• Oral pathology
• Odontogenic tumors
• Neoplastic dentistry

Background:

• Ameloblastic fibroma (AF) is a true mixed odontogenic tumor with neoplastic epithelial and ectomesenchymal components.
• Rare variants include granular cell AF and peripheral AF.
• Ameloblastic fibrosarcoma is the malignant counterpart of AF.

Purpose of the Study:

• To differentiate between benign ameloblastic fibroma and its malignant counterpart, ameloblastic fibrosarcoma.
• To analyze the biological behavior of AF variants using immunohistochemistry.
• To clarify the classification and nature of ameloblastic fibrodentinoma and ameloblastic fibro-odontoma.

Main Methods:

• Immunohistochemical analysis using MIB-1.
• Histopathological examination of odontogenic tumors.
• Review of WHO's classification of odontogenic tumors.

Main Results:

• Recurrent AF and ameloblastic fibrosarcoma show high MIB-1 labeling indices in the mesenchymal component compared to conventional AF.
• Ameloblastic fibrodentinoma exhibits similar biological behavior to conventional AF.
• Ameloblastic fibro-odontoma can show neoplastic behavior and has malignant potential, challenging its classification as purely hamartomatous.

Conclusions:

• MIB-1 labeling indices can help distinguish between benign and malignant/recurrent forms of ameloblastic fibroma.
• Ameloblastic fibrodentinoma and ameloblastic fibro-odontoma require careful histopathological evaluation due to their neoplastic potential.
• Clarification of odontogenic tumor classification is essential for accurate diagnosis and management.